Atlas market file ¡ Etf ¡ United States
iShares iBonds Dec 2032 Term Corporate ETFIBDX
- Last close
- 24.9
- Change
- +0.20%
- 96-bar range
- 24.77 â 25.525
- As of
- 7 Aug 2026
iShares iBonds Dec 2032 Term Corporate ETF is an exchange-traded fund listed as IBDX on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
⎠up candle ⎠down candle
Weekly outlook: the last 104 weekly closes (-2.51% over the window).
Source rail: Yahoo Finance chart API (IBDX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView ¡ provider feed Open view ->
Open the attributed TradingView market view for IBDX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IBDX public profile
Exchange-traded fund. iShares iBonds Dec 2032 Term Corporate ETF is connected to current market context, cited company sources and its retained research file.
iShares iBonds Dec 2032 Term Corporate ETF trades as IBDX on AMEX. iShares iBonds Dec 2032 Term Corporate ETF (IBDX) has a latest verified close of 24.9, up 0.20%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. IBDX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares iBonds Dec 2032 Term Corporate ETF today
iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is a fixed-maturity, investment-grade corporate-bond portfolio designed to return principal in December 2032, not to deliver perpetual growth. The wrapper promises a tidy exit in six yearsâ time, but the actual work is done by a Bloomberg index of US dollar bonds that mature in or near that month, selected and held until the fundâs wind-up. The glossy pitch frames it as a way to capture growth and innovation via an ETF, but the basket itself is a static ladder of investment-grade credit due in late 2032, not a dynamic AI or tech basket. The issuerâs own disclosures caution that most UK regulatory protections do not apply to the operation of the product, a detail that sits quietly beneath the marketing emphasis on scale and global reach.
The fund is listed on Nasdaq, meaning you can trade IBDX on-exchange like any ETF, but its liquidity is a function of the underlying bond marketâs depth. The issuerâs product page repeatedly underscores BlackRockâs scale as the worldâs largest ETF provider-evidence designed to reassure, but not to explain what the bonds inside are doing or how the annual fee is justified. The same page notes that protections provided by the UK system do not apply and compensation will not be available under the Financial Services Compensation Scheme in the event of default, a limitation that sits in stark contrast to the polished narrative of innovation and expert management.
The SEC EDGAR fund search confirms IBDXâs listing as an iShares term ETF with a maturity target of December 2032, and the issuerâs UK site reiterates that the product is authorised for distribution in the UK and listed on principal European exchanges, though the regulatory caveats remain unchanged. The FINRA Fund Analyzer provides the expense ratio and fee schedule, but the headline figure is dwarfed by the broader caveats about regulatory safeguards. In short, the wrapperâs marketing sells a theme of growth and innovation, while the fund itself is a fixed-income maturity ladder with an annual toll.
The Nasdaq listing page for IBDX offers market activity and pricing context, but it does not disclose the fundâs holdings, concentration, or yield-those details live in the prospectus and index methodology, which are not summarised on the exchangeâs site. The fundâs price action therefore reflects both the underlying bond market and the liquidity of the ETF wrapper, without the exchange providing the underlying data that would let traders see the gap between price and net asset value in real time. For a term ETF maturing in 2032, the spread between quoted price and fair value can widen when the bond market is thin or volatile, a risk that is visible in the mechanics but not quantified on the exchangeâs page.
The issuerâs repeated emphasis on scale and global distribution is supported by its own product rails, which show the iShares brand as the largest ETF provider worldwide. However, the same rails also include repeated disclaimers about the limits of UK investor protections and the absence of compensation in the event of default, which directly qualifies the glossy pitch. The fundâs value proposition-principal return at maturity-remains tethered to the credit quality and payment behaviour of the underlying issuers, not to the wrapperâs marketing imagery or the scale claims.
As of the last published data, the fundâs expense ratio is the annual toll for someone else to manage the maturity ladder, and the AUM figure is a snapshot that can fluctuate with flows and market moves. Neither the issuerâs marketing pages nor the exchangeâs listing page provide a rolling AUM figure or a holdings file on the same screen as the price quote, so the source requires readers to consult the fundâs prospectus or the index providerâs methodology to see the actual bonds and their weights. The absence of that data on the primary trading screen is a structural gap in the user experience, not a statement about the fundâs quality.
The fundâs mandate is simple: hold US dollar investment-grade corporate bonds maturing in or near December 2032 and return principal at maturity. The wrapperâs marketing, by contrast, leans on phrases like âcapture AIâs potential growthâ and âexpert management,â which sit uneasily beside a static maturity portfolio. The tension is not between good and bad; it is between the wrapperâs narrative and the fundâs mechanical reality. The wrapperâs claim to âfulfil investment objectives by concentrated industry-leading research and insightsâ is a marketing assertion that must be judged against the fundâs stated rules, not against an implied tech tilt.
Sources & evidence ¡ 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IBDX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IBDX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IBDX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IBDX FAQ
What is iShares iBonds Dec 2032 Term Corporate ETF (IBDX)?iShares iBonds Dec 2032 Term Corporate ETF (IBDX) has a latest verified close of 24.9, up 0.20%, dated 7 Aug 2026. Use this page to check the price chart, company...
iShares iBonds Dec 2032 Term Corporate ETF (IBDX) has a latest verified close of 24.9, up 0.20%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IBDX?iShares iBonds Dec 2032 Term Corporate ETF (IBDX) has a latest verified close of 24.9, up 0.20%, dated 7 Aug 2026. It brings the latest available chart, company...
iShares iBonds Dec 2032 Term Corporate ETF (IBDX) has a latest verified close of 24.9, up 0.20%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. IBDX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the IBDX page updated?The IBDX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IBDX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IBDX?The IBDX file starts with Nasdaq Trader and TradingView AMEX:IBDX. The page separates verified market context from company evidence and shows open evidence gaps instead...
The IBDX file starts with Nasdaq Trader and TradingView AMEX:IBDX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IBDX?Yes. The workstation can open IBDX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IBDX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IBDX page investment advice?No. The IBDX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IBDX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes â
IBDX
Etf ¡ evidence first